Hanwha Life stock faces earnings and dividend risks
Published on 11/01/2026 at 00:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey risks for upcoming results
- Investment-market volatility is expected to weigh on Hanwha Life's quarterly performance.
- The suspension of a flagship whole-life product creates uncertainty for new business.
- Dividend resumption remains dependent on regulatory changes affecting surrender-value reserves.
Hanwha Life Insurance faces a weaker earnings outlook after iM Securities projected a third-quarter loss, according to a report published by Seoul Economic Daily on Wednesday, October 21.
Investment losses drive earnings concerns
iM Securities projected a separate-basis net loss of 75.5 billion Korean won for the third quarter, reversing a profit recorded a year earlier. The brokerage attributed the expected weakness mainly to investment losses and estimated a third-quarter investment result of negative 206.6 billion Korean won.
The report said higher interest rates, currency effects and hedging losses linked to variable insurance could weigh on financial assets and investment returns. By contrast, insurance operations were expected to remain profitable, supported in part by a favorable comparison with the prior-year period.
Product sales and dividends remain focus areas
Hanwha Life has halted sales of its flagship whole-life insurance product, adding uncertainty to future new-business growth. iM Securities expected new protection-policy annualized premium equivalent to decline from the previous quarter, while the contractual service margin was projected to increase from a year earlier.
Dividend prospects also remain uncertain because regulatory changes related to surrender-value reserves have been delayed. Investors will therefore focus on the insurer's third-quarter results, the outlook for new contracts and any indication of when dividend payments could resume.
The Hanwha Life stock quote is available on the company page.
The KOSPI provides the broader market context for South Korean equities: KOSPI market coverage.
More news and analyses on Hanwha Life stock
Hanwha Life Insurance at a glance
- Company: Hanwha Life Insurance Co., Ltd.
- ISIN: KR7088350004
- Ticker: 088350.KS
- Listing: Korea Exchange
